retatrutide phase 2 trial obesity nejm 2023 Another Promising Medication (Retatrutide) for Retatrutide, a TRIPLE agonist (GLP1,

My last name is Stack, Fat is not my first name, although it felt like it was throughout certain portions of my life

GLP-1 receptor agonists are medications commonly prescribed to help manage type 2 diabetes and, in some cases, support medically supervised weight management

In the Phase 2 trial published in the New England Journal of Medicine (2023), retatrutide was administered as a once-weekly subcutaneous injection using a structured dose-escalation schedule

International Organization for Standardization

Semaglutide with B12 works by mimicking the GLP-1 hormone to improve blood sugar level regulation and decrease appetite

By targeting glucagon receptors, Retatrutide directly increases energy expenditure and thermogenesis, promoting faster calorie burning and fat loss